The company is focused on robotic technology for spine surgical procedures. Here are five things to know about the company’s stock:
1. The one-year consensus price target is at $18.88.
2. The one-year high is $25.12 and the low is $9.63.
3. Mazor’s market cap is $246 million.
4. Zacks gave Mazor a 78 out of 265 industry rating based on competitors rating.
5. The 50-day moving average is $11; the 200-day moving average is $12.25.
More articles on orthopedic devices:
Spine device company stock report—5 key companies
Smith & Nephew revenue up 2% in 2014—10 things to know
27 spine devices receive FDA 510(k) in January
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
